Table 1.
Demographic Characteristics of Patients with Documented Exposure to Gonadotoxic Chemotherapeutic Agents by Counseling Status
| Counseling status | |||
|---|---|---|---|
| Variable | Yes, N (%) | Not applicable, N (%) | No, N (%) |
| Ethnicity | |||
| Caucasian | 96 (60.0) | 36 (60.0) | 7 (43.8) |
| African American | 20 (12.5) | 12 (20.0) | 2 (12.5) |
| Asian | 11 (6.9) | 5 (8.3) | 1 (6.3) |
| Hispanic | 5 (3.1) | 1 (1.7) | — |
| Other/unknown | 28 (17.5) | 6 (10.0) | 6 (37.6) |
| Marital status | |||
| Single | 71 (44.4) | 16 (26.7) | 9 (56.3) |
| Married | 84 (52.5) | 37 (61.7) | 7 (43.8) |
| Divorced | 3 (1.9) | 6 (10.0) | — |
| Unknown | 2 (1.3) | 1 (1.7) | — |
| Cancer diagnosis | |||
| Breast | 99 (61.9) | 50 (83.3) | 15 (83.8) |
| Gynecological | 19 (11.9) | 6 (10.0) | — |
| Hematological | 42 (26.3) | 4 (6.7) | 1 (6.3) |
| Cancer stage | |||
| I | 18 (11.3) | 2 (3.3) | 1 (6.3) |
| II | 61 (38.1) | 26 (43.3) | 8 (50.0) |
| III | 21 (13.1) | 12 (20.0) | — |
| IV | 5 (3.1) | 3 (5.0) | — |
| Unknown | 55 (34.4) | 17 (28.3) | 7 (43.8) |
| Year of diagnosis | |||
| 2009 | 41 (25.6) | 19 (31.7) | 4 (25.0) |
| 2010 | 39 (24.4) | 8 (13.3) | 2 (12.5) |
| 2011 | 28 (17.5) | 6 (10.0) | 2 (12.5) |
| 2012 | 29 (18.1) | 11 (18.3) | 1 (6.3) |
| 2013 | 23 (14.4) | 16 (26.7) | 7 (43.8) |
| Insurance coverage | |||
| Private insurance | 129 (80.6) | 47 (78.3) | 10 (62.5) |
| Medicaid/Medicare/self-pay | 26 (16.3) | 9 (15.0) | 2 (12.5) |
| Unknown | 5 (3.1) | 4 (6.7) | 4 (25.0) |